Evaluation of the safety of a coumarin–troxerutin combination
Identifieur interne : 00B525 ( Main/Exploration ); précédent : 00B524; suivant : 00B526Evaluation of the safety of a coumarin–troxerutin combination
Auteurs : Robert Bruppacher [Suisse] ; Bernd Rieckemann [Allemagne] ; Belal Naser-Hijazi [Allemagne] ; Peter Wüstenberg [Allemagne]Source :
- Pharmacoepidemiology and Drug Safety [ 1053-8569 ] ; 1998-08.
Abstract
Concerns about liver reactions reported for coumarin preparations prompted a re‐evaluation of the combination of coumarin with troxerutin, widely used since 1971 in Germany. No evidence of liver toxicity could be found in available clinical research data. We estimated the number of coincidental cases of unexplained clinically apparent liver disease expected to arise during the patient treatment time on the basis of sales and the maximal recommended daily dosage. A comparison to the number of spontaneous reports yielded reassuring results. © 1998 John Wiley & Sons, Ltd.
Url:
DOI: 10.1002/(SICI)1099-1557(199808)7:1+
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 006765
- to stream Istex, to step Curation: 006765
- to stream Istex, to step Checkpoint: 003C60
- to stream Main, to step Merge: 00BC38
- to stream Main, to step Curation: 00B525
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of the safety of a coumarin–troxerutin combination</title>
<author><name sortKey="Bruppacher, Robert" sort="Bruppacher, Robert" uniqKey="Bruppacher R" first="Robert" last="Bruppacher">Robert Bruppacher</name>
</author>
<author><name sortKey="Rieckemann, Bernd" sort="Rieckemann, Bernd" uniqKey="Rieckemann B" first="Bernd" last="Rieckemann">Bernd Rieckemann</name>
</author>
<author><name sortKey="Naser Ijazi, Belal" sort="Naser Ijazi, Belal" uniqKey="Naser Ijazi B" first="Belal" last="Naser-Hijazi">Belal Naser-Hijazi</name>
</author>
<author><name sortKey="Wustenberg, Peter" sort="Wustenberg, Peter" uniqKey="Wustenberg P" first="Peter" last="Wüstenberg">Peter Wüstenberg</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:DD213A52F6D4B2C457ED5768ECE4A63620B355D4</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1002/(SICI)1099-1557(199808)7:1+3.0.CO;2-J</idno>
<idno type="url">https://api.istex.fr/document/DD213A52F6D4B2C457ED5768ECE4A63620B355D4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">006765</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006765</idno>
<idno type="wicri:Area/Istex/Curation">006765</idno>
<idno type="wicri:Area/Istex/Checkpoint">003C60</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">003C60</idno>
<idno type="wicri:doubleKey">1053-8569:1998:Bruppacher R:evaluation:of:the</idno>
<idno type="wicri:Area/Main/Merge">00BC38</idno>
<idno type="wicri:Area/Main/Curation">00B525</idno>
<idno type="wicri:Area/Main/Exploration">00B525</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Evaluation of the safety of a coumarin–troxerutin combination</title>
<author><name sortKey="Bruppacher, Robert" sort="Bruppacher, Robert" uniqKey="Bruppacher R" first="Robert" last="Bruppacher">Robert Bruppacher</name>
<affiliation wicri:level="1"><country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institut of Social‐ and Preventive Medicine, University of Basel, CH‐4051 Basel</wicri:regionArea>
<wicri:noRegion>CH‐4051 Basel</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Suisse</country>
<wicri:regionArea>Alleeweg 8, CH‐4310 Rheinfelden</wicri:regionArea>
<wicri:noRegion>CH‐4310 Rheinfelden</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rieckemann, Bernd" sort="Rieckemann, Bernd" uniqKey="Rieckemann B" first="Bernd" last="Rieckemann">Bernd Rieckemann</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Schaper & Brümmer GmbH & Co. KG, 38259 Salzgitter‐Ringelheim</wicri:regionArea>
<wicri:noRegion>38259 Salzgitter‐Ringelheim</wicri:noRegion>
<wicri:noRegion>38259 Salzgitter‐Ringelheim</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Naser Ijazi, Belal" sort="Naser Ijazi, Belal" uniqKey="Naser Ijazi B" first="Belal" last="Naser-Hijazi">Belal Naser-Hijazi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Schaper & Brümmer GmbH & Co. KG, 38259 Salzgitter‐Ringelheim</wicri:regionArea>
<wicri:noRegion>38259 Salzgitter‐Ringelheim</wicri:noRegion>
<wicri:noRegion>38259 Salzgitter‐Ringelheim</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wustenberg, Peter" sort="Wustenberg, Peter" uniqKey="Wustenberg P" first="Peter" last="Wüstenberg">Peter Wüstenberg</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Schaper & Brümmer GmbH & Co. KG, 38259 Salzgitter‐Ringelheim</wicri:regionArea>
<wicri:noRegion>38259 Salzgitter‐Ringelheim</wicri:noRegion>
<wicri:noRegion>38259 Salzgitter‐Ringelheim</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Pharmacoepidemiology and Drug Safety</title>
<title level="j" type="alt">PHARMACOEPIDEMIOLOGY AND DRUG SAFETY</title>
<idno type="ISSN">1053-8569</idno>
<idno type="eISSN">1099-1557</idno>
<imprint><biblScope unit="vol">7</biblScope>
<biblScope unit="issue">S1</biblScope>
<biblScope unit="page" from="S37">S37</biblScope>
<biblScope unit="page" to="S40">S40</biblScope>
<biblScope unit="page-count">4</biblScope>
<publisher>John Wiley & Sons, Ltd.</publisher>
<pubPlace>Chichester</pubPlace>
<date type="published" when="1998-08">1998-08</date>
</imprint>
<idno type="ISSN">1053-8569</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1053-8569</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Concerns about liver reactions reported for coumarin preparations prompted a re‐evaluation of the combination of coumarin with troxerutin, widely used since 1971 in Germany. No evidence of liver toxicity could be found in available clinical research data. We estimated the number of coincidental cases of unexplained clinically apparent liver disease expected to arise during the patient treatment time on the basis of sales and the maximal recommended daily dosage. A comparison to the number of spontaneous reports yielded reassuring results. © 1998 John Wiley & Sons, Ltd.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Suisse</li>
</country>
</list>
<tree><country name="Suisse"><noRegion><name sortKey="Bruppacher, Robert" sort="Bruppacher, Robert" uniqKey="Bruppacher R" first="Robert" last="Bruppacher">Robert Bruppacher</name>
</noRegion>
<name sortKey="Bruppacher, Robert" sort="Bruppacher, Robert" uniqKey="Bruppacher R" first="Robert" last="Bruppacher">Robert Bruppacher</name>
</country>
<country name="Allemagne"><noRegion><name sortKey="Rieckemann, Bernd" sort="Rieckemann, Bernd" uniqKey="Rieckemann B" first="Bernd" last="Rieckemann">Bernd Rieckemann</name>
</noRegion>
<name sortKey="Naser Ijazi, Belal" sort="Naser Ijazi, Belal" uniqKey="Naser Ijazi B" first="Belal" last="Naser-Hijazi">Belal Naser-Hijazi</name>
<name sortKey="Wustenberg, Peter" sort="Wustenberg, Peter" uniqKey="Wustenberg P" first="Peter" last="Wüstenberg">Peter Wüstenberg</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B525 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00B525 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:DD213A52F6D4B2C457ED5768ECE4A63620B355D4 |texte= Evaluation of the safety of a coumarin–troxerutin combination }}
This area was generated with Dilib version V0.6.31. |